Clinical Trials
All Clinical Trials - Page 55 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02217839Phase 1Completed
Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173
Octreotide
- NCT01576900N/ACompleted
The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia
Desmopressin
- NCT01582542Phase 4Unknown
Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction
Desmopressin
- NCT01547299Phase 2Completed
Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
Gonadorelin
- NCT01538966N/ATerminated
Acromegaly Combination Treatment Study
Octreotide
- NCT01439997Phase 4Completed
Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study
Desmopressin
- NCT01206101Phase 2Terminated
Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
Liraglutide
- NCT01581359Phase 4Completed
The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis
Gonadorelin
- NCT01682642Phase 4Completed
The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis.
Gonadorelin
- NCT01452685Phase 2Completed
A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis
Gonadorelin
- NCT01562678Phase 4Completed
Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
Liraglutide
- NCT01558271Phase 3Completed
A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
Liraglutide
- NCT01524770Phase 1Completed
A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe
Dulaglutide
- NCT01444898N/ACompleted
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
Exenatide
- NCT01590433Phase 4Completed
Weight Loss With Exenatide Treatment
Exenatide
- NCT01551602Phase 1Completed
Clinical Study of AK159 in Healthy Postmenopausal Women
Teriparatide
- NCT02021942Phase 2Completed
Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size
Octreotide
- NCT01412424Phase 3Completed
Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly
Octreotide
- NCT01552395N/ACompleted
A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia
Desmopressin
- NCT01742689Phase 3Unknown
Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic
Desmopressin
- NCT01552343Phase 3Completed
Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary
Desmopressin
- NCT01530451Phase 3Terminated
Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
Desmopressin
- NCT01619865Phase 1/Phase 2Completed
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors
Octreotide
- NCT01546454N/ACompleted
Relationship Between the Menstrual Cycle and Heart Disease in Women
Gonadorelin
- NCT01542242Phase 4Terminated
Liraglutide Use in Prader-Willi Syndrome
Liraglutide
- NCT01782261Phase 2Completed
Incretin Effect on the Immunological Phenotype
Liraglutide
- NCT01392898N/AUnknown
Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
Liraglutide
- NCT01536665Phase 1Completed
The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
Liraglutide
- NCT01517412Phase 3Completed
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Lixisenatide
- NCT01473589Phase 3Completed
Effect of Teriparatide on Hip Fracture Healing
Teriparatide
- NCT01512108Phase 3Completed
Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
Liraglutide
- NCT01518985Phase 1Completed
The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking
Elamipretide
- NCT01519349Phase 1Completed
Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
Follistatin
- NCT01492972Phase 3Recruiting
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Gonadorelin
- NCT02104037N/ACompleted
Liraglutide in Spinal Fluid
Liraglutide
- NCT01232946N/ACompleted
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
Liraglutide
- NCT01518101Phase 4Completed
Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
Liraglutide
- NCT01425580Phase 2Completed
Liraglutide and Heart Failure in Type 2 Diabetes
Liraglutide
- NCT01469351N/ACompleted
Identifying Potential Effects of Liraglutide on Degenerative Changes
Liraglutide
- NCT01505673Phase 4Completed
Adding Liraglutide to High Dose Insulin: Breaking the Cycle
Liraglutide
- NCT01687582N/ACompleted
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
Liraglutide
- NCT01511393N/AEnrolling By Invitation
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Liraglutide
- NCT01855490Phase 1Completed
Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
Exenatide
- NCT02431442Phase 1Completed
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers
Setmelanotide
- NCT01473602Phase 3Completed
Second Study of the Effect of Teriparatide on Hip Fracture Healing
Teriparatide
- NCT01760798N/AUnknown
Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
Teriparatide
- NCT01871844Phase 1Completed
ITF2984 Repeated Doses Study in Healthy Volunteers
Octreotide
- NCT01471405N/ACompleted
One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma
Lanreotide
- NCT01554618Phase 3Completed
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Exenatide
- NCT03923218N/ACompleted
Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37
Ll-37